Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NTRA
NTRA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NTRA News
Strait of Hormuz Reopening Boosts Healthcare Stocks
2d ago
Yahoo Finance
Latest Rating Changes on Wall Street
6d ago
CNBC
Natera Wins Patent Dispute, Secures 30% Ongoing Royalty
Apr 09 2026
seekingalpha
Natera Wins Patent Litigation Update with 30% Ongoing Royalty
Apr 09 2026
Newsfilter
Natera Showcases Advances in AI-Driven Genomics at AACR Annual Meeting
Apr 07 2026
Newsfilter
Natera's Signatera Study Published in Clinical Cancer Research
Mar 31 2026
Yahoo Finance
Signatera Enables Surgery Avoidance for Women Over 70
Mar 31 2026
Newsfilter
Signatera Assay Enhances High-Risk Patient Management
Mar 16 2026
Newsfilter
Natera (NTRA.US) Officer Plans to Sell $3.31 Million in Common Stock via Form 144
Mar 06 2026
moomoo
Exelixis Aims to Expand Beyond Cabozantinib Franchise
Feb 28 2026
NASDAQ.COM
Exelixis Aims to Become a Top Oncology Player with Expanding Pipeline
Feb 28 2026
Fool
Signatera MRD Enhances Quality of Life in Genitourinary Cancers
Feb 27 2026
Newsfilter
Natera Reports Record Q4 2025 Earnings with Strong Growth
Feb 27 2026
seekingalpha
Natera (NTRA) Q4 2025 Earnings Call Transcript
Feb 27 2026
NASDAQ.COM
Natera's Phase 2 Study of Signatera ctDNA Test Announced
Feb 24 2026
Yahoo Finance
SINERGY Trial Validates Signatera Treatment Approach with High Response Rate
Feb 24 2026
Newsfilter
Show More News
